Not yet recruiting
A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia
NCT06672263
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
- Henan Cancer Hospital Zhengzhou, Henan, China
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China